Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Long-term protection unveiled: hybrid immunity guards against Omicron reinfections

Researchers evaluated the impact of SARS-CoV-2 Wuhan-Hu-1 strain (WH1) immune imprinting on antibody-based immunological responses.

26 Jun 2023

Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

Recent research explores the impact of hybrid immunity and vaccine-only imprinting on omicron reinfection. Findings suggest effective protection and immune response in a long-term imprinted population.

25 Jun 2023

Prevalence study uncovers rising threat: enterovirus D68 and acute flaccid myelitis link

Study evaluated the changes in the transmission of EV-D68 in England inferred from seroprevalence data.

23 Jun 2023

Viral clearance: A potential predictor of COVID-19 treatment efficacy

Researchers determine the virological effects of COVID-19 treatment and its clinical efficacy in the same trial.

22 Jun 2023

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Researchers at the Ludwig Center at Harvard have developed a platform technology for imaging that enables integration of the methods of microscopic analysis long employed in pathology laboratories with the visualization of multiple molecular markers in individual cells that is now rapidly advancing in research labs.

22 Jun 2023

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical trial reported in the New England Journal of Medicine.

20 Jun 2023

Intranasal delivery of CRISPR/Cas9 therapeutics may help treat chronic anxiety

A study in mice reports a CRISPR/Cas9 gene-editing delivery system, capable of bypassing the blood-brain-barrier and modulating neuronal receptor pathways, to treat chronic anxiety.

20 Jun 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

Molecular cargo released by cancer cells lays the groundwork for leukemia spread

Tiny packets of molecular cargo shed by cancer cells seed the foundations for metastasis at distant sites in the body.

19 Jun 2023

Broader search needed for successful management of eosinophilic gastritis

The good news: a monoclonal antibody treatment called benralizumab proved quite effective in a clinical trial at depleting the number of eosinophils found in the blood and digestive tract tissues of patients with eosinophilic gastritis.

16 Jun 2023

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

From Catalent 16 Jun 2023

Researchers review the principles of universal vaccine development for key pandemic potential viruses

A recent review addressed the efforts to develop universal vaccines for viruses at family and genus levels.

16 Jun 2023

New approach improves diagnosis of limb-girdle muscular dystrophy

It's not easy to distinguish between the dozens of subtypes of limb girdle muscular dystrophy - a rare, genetic muscle disease characterized by weakness in the hips and shoulders that causes difficulty walking and lifting the arms.

15 Jun 2023

Phase 3 clinical trial shows favorable safety and immunogenicity profile of single-shot live-attenuated chikungunya vaccine

Researchers performed a double-blinded, phase III randomized trial.

15 Jun 2023

Antibody News and Research

Further Reading

Long-term protection unveiled: hybrid immunity guards against Omicron reinfections

Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

Prevalence study uncovers rising threat: enterovirus D68 and acute flaccid myelitis link

Viral clearance: A potential predictor of COVID-19 treatment efficacy

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Intranasal delivery of CRISPR/Cas9 therapeutics may help treat chronic anxiety

Battle against RSV: Computational design paves way for new polyvalent vaccine

Molecular cargo released by cancer cells lays the groundwork for leukemia spread

Broader search needed for successful management of eosinophilic gastritis

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Researchers review the principles of universal vaccine development for key pandemic potential viruses

New approach improves diagnosis of limb-girdle muscular dystrophy

Phase 3 clinical trial shows favorable safety and immunogenicity profile of single-shot live-attenuated chikungunya vaccine

What is the impact of maternal SARS-CoV-2 booster vaccination on antibodies in blood and breast milk?

An analysis of the differential effect and the impact of SARS-CoV-2 infection on semen quality

Study provides a new and promising strategy for future cancer immunotherapies

Sex differences contribute to age-related inflammation: Study

Manipulating white blood cells to eliminate solid tumors

Study suggests the role of histamine-releasing factor in severe asthma and RV-induced asthma exacerbation

How to make hybridoma-based antibody discovery more efficient eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo